NR-546 Midterm Exam 2026: Advanced Pharmacology
Psychopharmacology for PMHNP
EXAMINATION INSTRUCTIONS
Total Questions: 180
Time Allowed: 3 hours
Format: Multiple Choice (single answer) and Select-All-That-Apply
Passing Score: 80%
This comprehensive midterm examination assesses knowledge of advanced
psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner (PMHNP). Topics
include neuroanatomy, neurotransmitter systems, pharmacokinetics/pharmacodynamics,
psychotropic drug classes, mechanisms of action, adverse effects, drug interactions, and clinical
prescribing considerations across the lifespan.
SECTION A: FOUNDATIONS OF PSYCHOPHARMACOLOGY &
NEUROANATOMY (Questions 1-30)
Question 1
A PMHNP is reviewing the functional neuroanatomy of a patient with schizophrenia. Which
brain region is most closely associated with executive functions including working memory,
cognitive flexibility, and decision-making?
A. Amygdala
B. Dorsolateral prefrontal cortex (DLPFC)
C. Wernicke's area
D. Hippocampus
Answer: B. Dorsolateral prefrontal cortex (DLPFC)
Rationale: The dorsolateral prefrontal cortex is critical for executive functions including working
memory, abstract thinking, cognitive flexibility, and decision-making. The amygdala is primarily
involved in emotional processing and fear responses. Wernicke's area is associated with
language comprehension. The hippocampus is primarily involved in memory formation and
consolidation.
,Question 2
Which neurotransmitter is described as the "workhorse" of the brain, capable of affecting
almost every neuron and playing key roles in energy, memory, learning, and neural plasticity?
A. Serotonin
B. Dopamine
C. Glutamate
D. GABA
Answer: C. Glutamate
Rationale: Glutamate is an excitatory amino acid neurotransmitter that serves as the primary
excitatory neurotransmitter in the central nervous system. It is often called the "workhorse" of
the brain because it can affect almost every neuron and is involved in energy, memory, learning,
and neural plasticity. Excessive glutamate activity has been implicated in schizophrenia, epilepsy,
and mania. Glutamate receptors include NMDA and AMPA subtypes.
Question 3
The limbic system is often referred to as the "emotional brain." Which structures are considered
key components of the limbic system? (Select all that apply)
A. Amygdala
B. Hippocampus
C. Prefrontal cortex
D. Hypothalamus
Answer: A, B, C, D
Rationale: The limbic system includes the amygdala, hippocampus, hypothalamus, and
prefrontal cortex, among other structures. The amygdala is central to emotional processing and
fear responses. The hippocampus is critical for memory formation. The hypothalamus regulates
autonomic and endocrine functions. The prefrontal cortex is involved in emotional regulation
and executive function.
Question 4
,A patient presents with symptoms of anxiety and worry. The PMHNP understands that
norepinephrine (NE) neurons innervate which brain regions that are important to anxiety
processing?
A. Amygdala and prefrontal cortex
B. Basal ganglia and cerebellum
C. Brainstem and spinal cord
D. Thalamus and occipital cortex
Answer: A. Amygdala and prefrontal cortex
Rationale: Norepinephrine neurons innervate the amygdala and prefrontal cortex, areas of
importance to anxiety and worry. The amygdala processes emotional threats, while the
prefrontal cortex modulates emotional responses. Dysregulation of this NE pathway is
implicated in anxiety disorders.
Question 5
Which inhibitory neurotransmitter is responsible for decreasing neuroexcitability across the
brain and is often described as having a "chill" effect?
A. Glutamate
B. Dopamine
C. GABA
D. Acetylcholine
Answer: C. GABA
Rationale: GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the
brain. It decreases neuroexcitability across the brain and is often described as having a "chill"
effect. GABA works by opening chloride channels, hyperpolarizing neurons, and reducing
neuronal firing.
Question 6
A PMHNP is educating a patient about how medications work. The PMHNP explains that a drug
that binds to a receptor and produces a maximal response is called a:
A. Partial agonist
B. Antagonist
, C. Full agonist
D. Inverse agonist
Answer: C. Full agonist
Rationale: A full agonist binds to a receptor and produces a maximal biological response. A
partial agonist produces a submaximal response even at full receptor occupancy. An antagonist
binds to a receptor but produces no response, blocking the effects of agonists. An inverse
agonist produces effects opposite to those of an agonist.
Question 7
The PMHNP is reviewing genetic testing results for a patient. Understanding the cytochrome
P450 (CYP450) system is important because:
A. It determines which neurotransmitters are affected by medications
B. It provides information on how a patient may break down and metabolize medications
C. It identifies which psychiatric diagnosis the patient has
D. It predicts the patient's response to psychotherapy
Answer: B. It provides information on how a patient may break down and metabolize
medications
Rationale: Genetic testing can assist by providing information on how a client may break down
and metabolize medications based on the cytochrome P450 system. The CYP450 enzyme system
is responsible for the metabolism of most psychotropic medications. Understanding a patient's
genetic profile can guide medication selection and dosing.
Question 8
Which of the following is a key element of neurotransmission that PMHNPs must understand for
safe prescribing?
A. Neuroreceptors, neurotransmitters, and enzymatic reactions
B. Only the presynaptic neuron
C. Only the postsynaptic receptor
D. Only neurotransmitter reuptake
Answer: A. Neuroreceptors, neurotransmitters, and enzymatic reactions
Rationale: Key elements of neurotransmission include neuroreceptors, neurotransmitters, and
enzymatic reactions. Understanding these components is fundamental to understanding
Psychopharmacology for PMHNP
EXAMINATION INSTRUCTIONS
Total Questions: 180
Time Allowed: 3 hours
Format: Multiple Choice (single answer) and Select-All-That-Apply
Passing Score: 80%
This comprehensive midterm examination assesses knowledge of advanced
psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner (PMHNP). Topics
include neuroanatomy, neurotransmitter systems, pharmacokinetics/pharmacodynamics,
psychotropic drug classes, mechanisms of action, adverse effects, drug interactions, and clinical
prescribing considerations across the lifespan.
SECTION A: FOUNDATIONS OF PSYCHOPHARMACOLOGY &
NEUROANATOMY (Questions 1-30)
Question 1
A PMHNP is reviewing the functional neuroanatomy of a patient with schizophrenia. Which
brain region is most closely associated with executive functions including working memory,
cognitive flexibility, and decision-making?
A. Amygdala
B. Dorsolateral prefrontal cortex (DLPFC)
C. Wernicke's area
D. Hippocampus
Answer: B. Dorsolateral prefrontal cortex (DLPFC)
Rationale: The dorsolateral prefrontal cortex is critical for executive functions including working
memory, abstract thinking, cognitive flexibility, and decision-making. The amygdala is primarily
involved in emotional processing and fear responses. Wernicke's area is associated with
language comprehension. The hippocampus is primarily involved in memory formation and
consolidation.
,Question 2
Which neurotransmitter is described as the "workhorse" of the brain, capable of affecting
almost every neuron and playing key roles in energy, memory, learning, and neural plasticity?
A. Serotonin
B. Dopamine
C. Glutamate
D. GABA
Answer: C. Glutamate
Rationale: Glutamate is an excitatory amino acid neurotransmitter that serves as the primary
excitatory neurotransmitter in the central nervous system. It is often called the "workhorse" of
the brain because it can affect almost every neuron and is involved in energy, memory, learning,
and neural plasticity. Excessive glutamate activity has been implicated in schizophrenia, epilepsy,
and mania. Glutamate receptors include NMDA and AMPA subtypes.
Question 3
The limbic system is often referred to as the "emotional brain." Which structures are considered
key components of the limbic system? (Select all that apply)
A. Amygdala
B. Hippocampus
C. Prefrontal cortex
D. Hypothalamus
Answer: A, B, C, D
Rationale: The limbic system includes the amygdala, hippocampus, hypothalamus, and
prefrontal cortex, among other structures. The amygdala is central to emotional processing and
fear responses. The hippocampus is critical for memory formation. The hypothalamus regulates
autonomic and endocrine functions. The prefrontal cortex is involved in emotional regulation
and executive function.
Question 4
,A patient presents with symptoms of anxiety and worry. The PMHNP understands that
norepinephrine (NE) neurons innervate which brain regions that are important to anxiety
processing?
A. Amygdala and prefrontal cortex
B. Basal ganglia and cerebellum
C. Brainstem and spinal cord
D. Thalamus and occipital cortex
Answer: A. Amygdala and prefrontal cortex
Rationale: Norepinephrine neurons innervate the amygdala and prefrontal cortex, areas of
importance to anxiety and worry. The amygdala processes emotional threats, while the
prefrontal cortex modulates emotional responses. Dysregulation of this NE pathway is
implicated in anxiety disorders.
Question 5
Which inhibitory neurotransmitter is responsible for decreasing neuroexcitability across the
brain and is often described as having a "chill" effect?
A. Glutamate
B. Dopamine
C. GABA
D. Acetylcholine
Answer: C. GABA
Rationale: GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the
brain. It decreases neuroexcitability across the brain and is often described as having a "chill"
effect. GABA works by opening chloride channels, hyperpolarizing neurons, and reducing
neuronal firing.
Question 6
A PMHNP is educating a patient about how medications work. The PMHNP explains that a drug
that binds to a receptor and produces a maximal response is called a:
A. Partial agonist
B. Antagonist
, C. Full agonist
D. Inverse agonist
Answer: C. Full agonist
Rationale: A full agonist binds to a receptor and produces a maximal biological response. A
partial agonist produces a submaximal response even at full receptor occupancy. An antagonist
binds to a receptor but produces no response, blocking the effects of agonists. An inverse
agonist produces effects opposite to those of an agonist.
Question 7
The PMHNP is reviewing genetic testing results for a patient. Understanding the cytochrome
P450 (CYP450) system is important because:
A. It determines which neurotransmitters are affected by medications
B. It provides information on how a patient may break down and metabolize medications
C. It identifies which psychiatric diagnosis the patient has
D. It predicts the patient's response to psychotherapy
Answer: B. It provides information on how a patient may break down and metabolize
medications
Rationale: Genetic testing can assist by providing information on how a client may break down
and metabolize medications based on the cytochrome P450 system. The CYP450 enzyme system
is responsible for the metabolism of most psychotropic medications. Understanding a patient's
genetic profile can guide medication selection and dosing.
Question 8
Which of the following is a key element of neurotransmission that PMHNPs must understand for
safe prescribing?
A. Neuroreceptors, neurotransmitters, and enzymatic reactions
B. Only the presynaptic neuron
C. Only the postsynaptic receptor
D. Only neurotransmitter reuptake
Answer: A. Neuroreceptors, neurotransmitters, and enzymatic reactions
Rationale: Key elements of neurotransmission include neuroreceptors, neurotransmitters, and
enzymatic reactions. Understanding these components is fundamental to understanding
